Literature DB >> 11551871

Human evidence that the apolipoprotein a-II gene is implicated in visceral fat accumulation and metabolism of triglyceride-rich lipoproteins.

F M van 't Hooft1, G Ruotolo, S Boquist, U de Faire, G Eggertsen, A Hamsten.   

Abstract

BACKGROUND: Apolipoprotein (apo) A-II is a major structural protein of plasma HDLs, but little is known regarding its functions. METHODS AND
RESULTS: To investigate the physiological role of apoA-II in humans, we screened the promoter region of the apoA-II gene for a functional polymorphism and used this polymorphism as a tool in association studies. A common, functional polymorphism in the promoter region of the apoA-II gene, a T to C substitution at position -265, was found. Electrophoretic mobility shift assays demonstrated that the -265T/C polymorphism influences the binding of nuclear proteins, whereas transient transfection studies in human hepatoma cells showed a reduced basal rate of transcription of the -265C allele compared with the -265T allele. The -265C allele was associated with decreased plasma apoA-II concentration and decreased waist circumference in healthy 50-year-old men. In addition, oral fat tolerance tests provided evidence that the -265C allele enhances postprandial metabolism of large VLDLs.
CONCLUSIONS: ApoA-II appears to promote visceral fat accumulation and impair metabolism of large VLDLs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551871     DOI: 10.1161/hc3601.095709

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

1.  APOA2 -256T>C polymorphism interacts with saturated fatty acids intake to affect anthropometric and hormonal variables in type 2 diabetic patients.

Authors:  Marjan Ghane Basiri; Gity Sotoudeh; Ehsan Alvandi; Mahmood Djalali; Mohammad Reza Eshraghian; Neda Noorshahi; Fariba Koohdani
Journal:  Genes Nutr       Date:  2015-04-23       Impact factor: 5.523

2.  The interaction between ApoA2 -265T>C polymorphism and dietary fatty acids intake on oxidative stress in patients with type 2 diabetes mellitus.

Authors:  Elham Zamani; Haleh Sadrzadeh-Yeganeh; Gity Sotoudeh; Laleh Keramat; Mohammadreza Eshraghian; Masoumeh Rafiee; Fariba Koohdani
Journal:  Eur J Nutr       Date:  2016-06-06       Impact factor: 5.614

Review 3.  Dyslipidemia of the metabolic syndrome.

Authors:  Giacomo Ruotolo; Barbara V Howard
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

4.  Apolipoprotein-AII concentrations are associated with liver steatosis in patients with chronic hepatitis C.

Authors:  Jean Michel Petit; Valerie Jooste; Laurence Duvillard; Anne Minello; Véronique Texier; Françoise Galland; Philippe Gambert; Bruno Verges; Patrick Hillon
Journal:  Dig Dis Sci       Date:  2007-04-11       Impact factor: 3.199

5.  Human evidence for the involvement of insulin-induced gene 1 in the regulation of plasma glucose concentration.

Authors:  S Krapivner; E Chernogubova; M Ericsson; C Ahlbeck-Glader; A Hamsten; F M van 't Hooft
Journal:  Diabetologia       Date:  2006-11-15       Impact factor: 10.122

6.  APOA2, dietary fat, and body mass index: replication of a gene-diet interaction in 3 independent populations.

Authors:  Dolores Corella; Gina Peloso; Donna K Arnett; Serkalem Demissie; L Adrienne Cupples; Katherine Tucker; Chao-Qiang Lai; Laurence D Parnell; Oscar Coltell; Yu-Chi Lee; Jose M Ordovas
Journal:  Arch Intern Med       Date:  2009-11-09

7.  Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance.

Authors:  Lawrence W Castellani; Cara N Nguyen; Sarada Charugundla; Michael M Weinstein; Chau X Doan; William S Blaner; Nuttaporn Wongsiriroj; Aldons J Lusis
Journal:  J Biol Chem       Date:  2007-12-26       Impact factor: 5.157

8.  Apolipoprotein A2 polymorphism interacts with intakes of dairy foods to influence body weight in 2 U.S. populations.

Authors:  Caren E Smith; Katherine L Tucker; Donna K Arnett; Sabrina E Noel; Dolores Corella; Ingrid B Borecki; Mary F Feitosa; Stella Aslibekyan; Laurence D Parnell; Chao-Qiang Lai; Yu-Chi Lee; José M Ordovás
Journal:  J Nutr       Date:  2013-10-09       Impact factor: 4.798

Review 9.  HDL: bridging past and present with a look at the future.

Authors:  Angelo M Scanu; Celina Edelstein
Journal:  FASEB J       Date:  2008-08-20       Impact factor: 5.191

10.  Epigenomics and metabolomics reveal the mechanism of the APOA2-saturated fat intake interaction affecting obesity.

Authors:  Chao-Qiang Lai; Caren E Smith; Laurence D Parnell; Yu-Chi Lee; Dolores Corella; Paul Hopkins; Bertha A Hidalgo; Stella Aslibekyan; Michael A Province; Devin Absher; Donna K Arnett; Katherine L Tucker; Jose M Ordovas
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.